CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 258 filers reported holding CRISPR THERAPEUTICS AG in Q1 2020. The put-call ratio across all filers is 0.73 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $30,622,000 | +22.0% | 200,000 | -33.3% | 0.73% | -24.5% |
| Q3 2020 | $25,092,000 | -14.6% | 300,000 | -25.0% | 0.96% | -14.0% |
| Q2 2020 | $29,396,000 | +10.0% | 400,000 | -36.5% | 1.12% | -9.7% |
| Q1 2020 | $26,735,000 | -56.1% | 630,400 | -37.0% | 1.24% | -48.9% |
| Q4 2019 | $60,905,000 | +37.0% | 1,000,000 | -7.8% | 2.43% | -10.2% |
| Q3 2019 | $44,445,000 | +34.8% | 1,084,300 | +54.9% | 2.70% | +42.8% |
| Q2 2019 | $32,970,000 | +2.6% | 700,000 | -22.2% | 1.89% | -12.8% |
| Q1 2019 | $32,148,000 | +1025.2% | 900,000 | +800.0% | 2.17% | +836.6% |
| Q4 2018 | $2,857,000 | – | 100,000 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $32,581,000 | 55.55% |
| NEA Management Company, LLC | 1,590,002 | $103,907,000 | 5.19% |
| ARK Investment Management | 8,237,122 | $538,296,000 | 3.75% |
| Nikko Asset Management Americas, Inc. | 4,262,736 | $277,078,000 | 3.54% |
| CLOUGH CAPITAL PARTNERS L P | 414,767 | $27,105,000 | 2.89% |
| Integral Health Asset Management, LLC | 220,000 | $14,377,000 | 2.79% |
| PLUSTICK MANAGEMENT LLC | 50,000 | $3,268,000 | 2.48% |
| HC Advisors, LLC | 53,944 | $3,525,000 | 2.43% |
| Green Alpha Advisors, LLC | 27,466 | $1,795,000 | 1.52% |
| EFG Asset Management (North America) Corp. | 84,356 | $5,516,000 | 1.28% |